Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: GENSCRIPT USA INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-02-01 to 2024-03-31
Current total value of award: $12054.5
Description: ANTIBODY ENGINEERING WITH DNA